-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the past two years, under the cover of the epidemic, in the entire pharmaceutical and biological industry, in addition to the splendid performance of the sectors related to the epidemic, it is mainly the CXO sector.
Based on what has been published, we have sorted them out as follows:
In terms of revenue , it has basically maintained a substantial growth
In terms of revenue
In terms of net profit , most of them maintained rapid growth.
From net profit
In terms of market value , the current market value of WuXi is 480 billion yuan, and Pharmaron, Tigermed and Asymchem are more than 80 billion yuan
In terms of market value
From the perspective of main business structure , Jiuzhou Pharmaceutical, Puluo Pharmaceutical, Hepurui, Haoyuan Pharmaceutical, Nuotai Bio, etc.
From the perspective of main business structure
Reference: NMPA/CDE; Pharnexcloud data:FDA/EMA/PMDA; public disclosure of related companies;
Reference: NMPA/CDE; Pharnexcloud data:FDA/EMA/PMDA; public disclosure of related companies;
etc.
